Douglas F. Marks
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Mesenchymal stem cell research
- Virus-based gene therapy research
Papers in
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 3
-
- Hematopoietic Stem Cell Transplantation 3
- Co-authors
- Michael Alan Rosenzweig (5 shared papers)Richard C. Mulligan (1 shared paper)Glenn A. Paradis (1 shared paper)Stephen A. Grupp (1 shared paper)Colin A. Sieff (1 shared paper)Margaret A. Goodell (1 shared paper)MaryAnn DeMaria (1 shared paper)Hyung Lae Kim (1 shared paper)
- Journals
- Journal of Medical Primatology (2 papers)Blood (2 papers)Nature Medicine (1 paper)Experimental Hematology (1 paper)BMC Public Health (1 paper)
- Partner nations
- United StatesUnited KingdomSlovenia
In The Last Decade
Douglas F. Marks
10 papers receiving 1.1k citations
Douglas F. Marks's Hit Papers
Peers
Comparison fields: 5 of 85
- Hematology 359
- Genetics 308
- Oncology 298
- Immunology 200
- Molecular Biology 464
Countries citing papers authored by Douglas F. Marks
This map shows the geographic impact of Douglas F. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas F. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas F. Marks more than expected).
Fields of papers citing papers by Douglas F. Marks
This network shows the impact of papers produced by Douglas F. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas F. Marks. The network helps show where Douglas F. Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas F. Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species Hit paper breakdown → | 1997 | 949 |
| 2 | 1999 | 72 | |
| 3 | 2013 | 48 | |
| 4 | 1997 | 21 | |
| 5 | 1996 | 8 | |
| 6 | 2001 | 6 | |
| 7 | Does use of touch screen computer technology improve classroom engagement in children? | 2012 | 6 |
| 8 | 2010 | 3 | |
| 9 | Perceptions of Student Personnel Services at a Major Land Grant University. | 1980 | 1 |
| 10 | 1997 | 1 |
About Douglas F. Marks
Douglas F. Marks is a scholar working on Immunology, Hematology, Virology, Infectious Diseases and General Agricultural and Biological Sciences, having authored 10 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (3 papers), Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (3 papers), HIV/AIDS drug development and treatment (2 papers), HIV Research and Treatment (2 papers), CRISPR and Genetic Engineering (1 paper), CAR-T cell therapy research (1 paper) and Child Development and Digital Technology (1 paper). The work is most often cited by research in Hematology (359 citations), Genetics (308 citations), Oncology (298 citations), Immunology (200 citations) and Molecular Biology (464 citations). Douglas F. Marks has collaborated with scholars based in United States, United Kingdom and Slovenia. Frequent co-authors include Michael Alan Rosenzweig, Richard C. Mulligan, Glenn A. Paradis, Stephen A. Grupp, Colin A. Sieff, Margaret A. Goodell, MaryAnn DeMaria, Hyung Lae Kim, R. Paul Johnson and John M Burns. Their work appears in journals such as Journal of Medical Primatology, Blood, Nature Medicine, Experimental Hematology and BMC Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.